Ignite Creation Date:
2024-05-06 @ 9:27 AM
Last Modification Date:
2024-10-26 @ 12:14 PM
Study NCT ID:
NCT02983071
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-02-15
First Post:
2016-11-29
Brief Title:
G1T38 a CDK 46 Inhibitor in Combination With Fulvestrant in Hormone Receptor-Positive HER2-Negative Locally Advanced or Metastatic Breast Cancer
Sponsor:
G1 Therapeutics Inc
Organization:
G1 Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01
Start Date Type:
None
Primary Completion Date:
2023-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-10
Completion Date Type:
ESTIMATED
First Submit Date:
2016-11-29
First Submit QC Date:
December 1 2016
Study First Post Date:
2016-12-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-14
Last Update Post Date:
2023-02-15
Last Update Post Date Type:
ACTUAL